by Ket Patel | Nov 19, 2012 | Uncategorized
Patient survival after in-hospital cardiac arrest improved substantially in recent years, according to a report from a large registry published online Nov. 15 in the New England Journal of Medicine. Moreover, the rate of clinically significant neurologic disability...
by Ket Patel | Nov 11, 2012 | Slider Content
More than two-thirds of patients with medically refractory chronic cluster headache responded to on-demand, self-administered sphenopalatine ganglion stimulation with acute pain relief, less frequent attacks, or both. The prophylactic effect – a reduction in cluster...
by Ket Patel | Oct 29, 2012 | Slider Content
Occipital nerve blocks are an effective, safe, and well-tolerated therapy in patients with exacerbation of chronic or episodic cluster headache, according to two observational studies presented at the European Headache and Migraine Trust International Congress....
by Ket Patel | Oct 9, 2012 | Slider Content
Twenty-five percent of chronic migraine patients experience at least a 75% reduction in headache days per month after 6 months of treatment with onabotulinumtoxinA, according to a new analysis of data from the landmark PREEMPT trials. “That’s what I tell my...
by Ket Patel | Oct 9, 2012 | Uncategorized
Brief low-temperature radiofrequency rhizolysis of the C-1 spinal nerve and C-2 and C-3 dorsal root ganglia was safe and effective for occipital neuralgia with migraine in a retrospective series of 10 patients. “The pain reduction lasted for an average of 5½...
